MDCXW — Medicus Pharma Ltd. Warrant
NASDAQ
$0.33
+$0.00 (+0.00%)
Medicus Pharma Ltd. Warrant (MDCXW) common stock listed on NASDAQ. It is led by Raza Bokhari M.B.A., M.D., based in 300 Conshohocken State Road, West Conshohocken, PA, United States, 19428, with about 16 employees. Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Net income was -$16.0M.
Use this MDCXW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MDCXW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MDCXW SEC filings page. Lician reads the product cache first so this HTML stays unique to Medicus Pharma Ltd. Warrant even when a live quote feed is slow.
About Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
MDCXW Key Statistics
Market Cap
$0.00M
Volume
59
Previous Close
$0.33
Day Range
$0.33 – $0.33
EPS
-$1.16
Revenue
$0.00
Net Income
-$11.16M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
16
MDCXW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 |
| Net Income | -$11.16M | -$5.31M |
| EPS (Diluted) | -$1.16 | -$1.53 |
Total Assets
$5.65M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$4.16M
Operating Cash Flow
-$10.25M
Free Cash Flow
$0.00
Medicus Pharma Ltd. Warrant Company Information
- CEO & Executive Chairman
- Raza Bokhari M.B.A., M.D.
- Headquarters
- 300 Conshohocken State Road, West Conshohocken, PA, United States, 19428
- Website
- medicuspharma.com
- Phone
- 610 636 0184
- IPO / Founded
- 2024-11-14